Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Insulin Archives
Print | Email | Share | Comments (0)

Giants Join Forces

Oct 1, 1995

Novo Nordisk, the world's largest insulin producer, and LifeScan, Inc., the leading maker of blood glucose monitoring systems, have announced a worldwide alliance to enhance diabetes management solutions.

Under the agreement, the companies will work together to bring two complimentary product lines to people with diabetes-Novo Nordisk's insulin products and future oral hypoglycemic agents, and LifeScan's blood glucose meters. The details of the union will be determined on a country-by-country basis.

"By jointly marketing with Novo Nordisk," says LifeScan president Richard Wiesner, "we will be able to benefit from each other's strengths in providing people with diabetes and health professionals with simple, accessible solutions to their diabetes management needs."

LifeScan, an American company, brings extensive knowledge of the U.S. blood glucose monitoring market to the partnership. Novo Nordisk's experience in other countries, especially Europe and Japan, will help LifeScan globalize its activities. The alliance will offer people a complete diabetes management option that stresses the combination of therapeutics and glucose monitors, as well as educational material, therapeutic guidelines, and compliance programs.

Says Mads Ovlisen, president and CEO of Novo Nordisk, "With the application of optimal treatment guidelines, which include the availability and correct use of drugs and blood glucose monitoring systems, quality of care will increase and costs decrease."


Categories: Blood Glucose, Diabetes, General, Insulin, Novo Nordisk



You May Also Be Interested In...


Click Here To View Or Post Comments

Oct 1, 1995

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.